GlassScriptPhysician profile
Whitney Sage Smith
NPI 1255926267
$932.35
in general payments reported to CMS, 2019-2025
10 companies · $44.39 in 2025
The $44.39 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $430 · 2023: $117 · 2024: $147 · 2025: $44.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $230.42 | 2021-2022 | |
| Medtronic, INC. | $195.56 | 2022 | |
| Boston Scientific Corporation | $191.65 | 2024-2025 | Cds - Mct/Cem Monitoring, Bodyguardian |
| Abbvie INC. | $117.07 | 2023 | |
| Janssen Pharmaceuticals, INC | $48.70 | 2022 | |
| Amarin Pharma, INC. | $46.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.98 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.90 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.78 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.